Invitris YC 申请
Invitris 在 Winter 2023 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2023
- 行业
- HealthcareDrug Discovery and Delivery
- 团队规模
- 6
- 状态
- Active
- 已发布
- 2023
创始人
Patrick GrossmannFounder
Kilian VogeleFounder
Invitris 做什么
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.
Invitris 的 YC 申请，重建版
Y Combinator 申请
Invitris，Winter 2023 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Invitris
Creating new protein-based drugs at scale
We're building a platform that turns DNA into synthetic proteins to create new biological drugs. It makes designing and producing proteins more than 10,000 times more efficient and cuts material costs by over 100 times compared to traditional methods. Our first focus is synthetic bacteriophages to fight antibiotic-resistant infections, which are causing more deaths than all cancers combined.
We live and operate in Munich, Bavaria, Germany. After YC, we would continue to base the company here.
We're based in Munich because that's where we have access to our core team and labs, and Germany has a strong biotech ecosystem that supports our work.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。
常见问题解答
这是 Invitris 的真实 YC 申请吗？
不是。Y Combinator 对提交的申请保密。这是重建版：使用 Invitris 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Invitris 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。
Invitris 是哪个 YC 批次的？
Invitris 是 Y Combinator Winter 2023 批次的成员。
谁创立了 Invitris？
Invitris 由 Patrick Grossmann, Kilian Vogele 创立。
Invitris 做什么？
Creating new protein-based drugs at scale
如何阅读完整的重建申请？
创建免费的 Round Funded 账户。YC Insights 中包含 Invitris 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。
